Skip to main content
Midas Edge

MEDIFAST INC

For the period ended Dec 31, 2025. Filed Feb 17, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 17, 2026

MED$12.81+0.6%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Page
PART I
Item 1Business4
Item 1ARisk Factors17
Item 1BUnresolved Staff Comments27
Item 1CCybersecurity27
Item 2Properties29
Item 3Legal Proceedings29
Item 4Mine Safety Disclosures29
PART II
Item 5Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities30
Item 6Reserved32
Item 7Management’s Discussion and Analysis of Financial Condition and Results of Operations33
Item 7AQuantitative and Qualitative Disclosures about Market Risk32
Item 8Financial Statements and Supplementary Data38
Item 9Changes in and Disagreements with Accountants on Accounting and Financial Disclosures63
Item 9AControls and Procedures63
Item 9BOther Information64
Item 9CDisclosure Regarding Foreign Jurisdictions That Prevent Inspections64
PART III
Item 10Directors, Executive Officers and Corporate Governance65
Item 11Executive Compensation65
Item 12Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters65
Item 13Certain Relationships and Related Transactions, and Director Independence65
Item 14Principal Accountant Fees and Services65
PART IV
Item 15Exhibits and Financial Statement Schedules66
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.